Beyond the Pages: CCJM Podcast

Alpha-1 antitrypsin deficiency

In this podcast featuring the Cleveland Clinic Journal of Medicine commentary, “Alpha-1 antitrypsin deficiency: A persistently underrecognized condition,” author James K. Stoller, MD, MS, Cleveland Clinic, joins moderator and Cleveland Clinic Journal of Medicine Editor-in-Chief Brian Mandell, MD, PhD. The podcast discusses the underrecognized nature of alpha-1 antitrypsin deficiency, causing harm, and reviews both established guideline-based and emerging AI-supported strategies to improve its detection.

AI in Medicine PART TWO

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Artificial intelligence in medicine: How it works, how it fails,” authors Rick Rejeleene, PhD, and Neil B. Mehta, MBBS, MS, join moderator Adam Brown, MD, Cleveland Clinic. The trio discusses AI’s transformation of healthcare, with large language models emerging as important tools for clinical practice, education, and research.

AI in Medicine PART ONE

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Artificial intelligence in medicine: How it works, how it fails,” authors Rick Rejeleene, PhD, and Neil B. Mehta, MBBS, MS, join moderator Adam Brown, MD, Cleveland Clinic. The trio discusses AI’s transformation of healthcare, with large language models emerging as important tools for clinical practice, education, and research.

Complement inhibition PART TWO

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune system.

Complement inhibition PART ONE

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune system.

Update on antiobesity medications in adults PART TWO

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

Update on antiobesity medications in adults PART ONE

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

Lipoprotein(a) in clinical practice

Listen as Dr. Astefanos Al-Dalakta and Dr. Ashish Sarraju, Cleveland Clinic, join moderator Dr. George Thomas, Cleveland Clinic, to discuss what clinicians need to know about lipoprotein(a) in clinical practice. Topics discussed include summarizes evidence on risk, screening strategies, and evolving therapies for elevated lipoprotein(a).

Testing for PFAS ‘forever chemicals’ PART TWO

This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

Testing for PFAS ‘forever chemicals’ PART ONE

This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

Single-pill combination antihypertensive therapy

This podcast moderated by Dr. Craig Nielsen features a discussion with Dr. Maximilian C. Volk, and Dr. Luke J. Laffin, Cleveland Clinic on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Should I consider Cy for my patient with high blood pressure?”

Hypercholesterolemia not responding to statins

This podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Dr. Faaiq N. Aslam, Mayo Clinic, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “My adult patient’s hypercholesterolemia is not responding to statins—what’s next?”

• Transcript

Recreational cannabis legalization

This podcast features discussion with Dr. Akhil Anand and Dr. Hannah Snyder, and moderated by Dr. Craig Nielsen, all of Cleveland Clinic. Together, they explore the Cleveland Clinic Journal of Medicine article, “Recreational cannabis legalization: Potential implications for individual and community health.” The conversation delves into the multifaceted issues surrounding recreational cannabis legalization, examining potential health and societal outcomes.

• Transcript

Psychedelic assisted therapy PART TWO

In this two-part podcast, Dr. Brian S. Barnett, Cleveland Clinic, and Dr. Erin E. Mauney, Massachusetts General Hospital for Children, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Psychedelic assisted therapy: An overview for the internist.” The trio focuses on what an internist needs to know, from the potential effects, risks, and therapeutic applications of these powerful drugs, with a focus on MDMA-assisted therapy for posttraumatic stress disorder (PTSD) and psilocybin-assisted therapy for depression.

Psychedelic assisted therapy PART ONE

In this two-part podcast, Dr. Brian S. Barnett, Cleveland Clinic, and Dr. Erin E. Mauney, Massachusetts General Hospital for Children, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Psychedelic assisted therapy: An overview for the internist.” The trio focuses on what an internist needs to know, from the potential effects, risks, and therapeutic applications of these powerful drugs, with a focus on MDMA-assisted therapy for posttraumatic stress disorder (PTSD) and psilocybin-assisted therapy for depression.

Diabetes technology PART TWO

In this two-part podcast, Dr. Cecila Lansang, Cleveland Clinic, and Dr. Jayachidambaram Ambalavanan, Maine Health, joins moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Diabetes technology: A primer for clinicians.” The trio discusses the evolution of diabetes technology it’s impact on the way that both patients and clinicians approach the management of diabetes.

Diabetes technology PART ONE

In this two-part podcast, Dr. Cecila Lansang, Cleveland Clinic, and Dr. Jayachidambaram Ambalavanan, Maine Health, joins moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Diabetes technology: A primer for clinicians.” The trio discusses the evolution of diabetes technology it’s impact on the way that both patients and clinicians approach the management of diabetes.

Unprovoked Venous Thromboembolism

Listen as Neeladri Misra, MD, Sutter Roseville Medical Center, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss a one-minute consult article that answers the question “Should every patient with an unprovoked venous thromboembolism have a hypercoagulable workup?”

Vaccine hesitancy in the time of COVID, PART TWO

In a two-part podcast, listen as Dr. H. Clifford Lane, National Institute of Allergy and Infectious Diseases, and Dr. Steven M. Gordon, Cleveland Clinic, join moderator Dr. Brian Mandell, Editor-in-Chief of Cleveland Clinic Journal of Medicine, to discuss vaccine hesitancy in the time of COVID. Topics discussed include the historical context of vaccine hesitancy, current knowledge and gaps regarding COVID-19 vaccines, and how to effectively guide patients in making informed decisions about COVID-19 vaccination.

Vaccine hesitancy in the time of COVID, PART ONE

Listen as Dr. H. Clifford Lane, National Institute of Allergy and Infectious Diseases, and Dr. Steven M. Gordon, Cleveland Clinic, join moderator Dr. Brian Mandell, Editor-in-Chief of Cleveland Clinic Journal of Medicine, to discuss the historical context of vaccine hesitancy, current knowledge and gaps regarding COVID-19 vaccines, and how to effectively guide patients in making informed decisions about COVID-19 vaccination.